Thomas Jefferson University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDPH71571D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

September 2018

Total pages

41

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Thomas Jefferson University (Thomas Jefferson) is an educational university that offers graduate, postdoctoral, and research training in the biomedical sciences. The university's activities include educating professionals, discovering knowledge, and patient care. It offers programs such as continuing nursing education, continuing pharmacy education, continuing medical education, population health forum and ultrasound radiology and education. Thomas Jefferson conducts research activities through its departments, centers and institutes, medical college research, student research opportunities, and others. The university operates through its offices located in Pennsylvania, New Jersey and Delaware. Thomas Jefferson is headquartered in Philadelphia, Pennsylvania, the US.

Thomas Jefferson University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Thomas Jefferson University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Thomas Jefferson University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Thomas Jefferson University, Medical Devices Deals, 2012 to YTD 2018 10

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Genisphere Enters into Research Agreement with Sidney Kimmel 12

Bio-Path Enters into Research Agreement with Thomas Jefferson University 13

Exosome Sciences Enters into Research Agreement with Thomas Jefferson 14

Imcare Biotech Enters into Development Partnership with Thomas Jefferson University 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Nanobiotix Enters Into Co-Development Agreement With Thomas Jefferson University For Nbtxr3 17

Merger 18

Abington Health Merges with Thomas Jefferson University 18

Licensing Agreements 19

BioVaxys Enters into Licensing Agreement with Thomas Jefferson University 19

Junaxo Enters into Licensing Agreement with Thomas Jefferson University 20

Clementia Pharma Enters into Licensing Agreement with Thomas Jefferson University 21

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23

Thomas Jefferson University-Key Competitors 24

Thomas Jefferson University-Key Employees 25

Thomas Jefferson University-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 28

Strategy And Business Planning 28

Apr 16, 2018: Geisinger expands access to clinical trials through consortium with five other health systems 28

Government and Public Interest 30

Apr 16, 2018: Drexel Joins Regional Health Systems to Expand Access to Clinical Trials 30

Apr 16, 2018: Six Health Systems form Consortium to Expand Access to Clinical Trials, Bringing Access to Clinical Trials Closer to Home 31

Apr 10, 2018: Nanoparticles for Lung Cancer Pass Next Test 32

Mar 26, 2018: New Targeted Therapy Schedule Could Keep Melanoma At Bay 33

Mar 06, 2018: Restoring Lipid Synthesis Could Reduce Lung Fibrosis 34

Jan 16, 2018: Magnetically Applied MicroRNAs Could One Day Help Relieve Constipation 35

Dec 14, 2017: New Recommendations Provide Guidance on Genetic Counseling and Genetic Testing for Hereditary Prostate Cancer 36

Nov 21, 2017: Lankenau Institute for Medical Research investigators uncover new therapeutic target for pancreatitis, a risk factor for pancreatic cancer 37

May 24, 2017: Jefferson researcher identifies targets for better anti-thrombotic medicine 38

Other Significant Developments 39

Jul 05, 2018: Revving Up Innate Control of Viral Infection Requires a Three-Cell Ignition 39

Jan 18, 2018: Lung Cancer Patients to Help Medical Community Understand the Side Effects of Immunotherapy Treatment 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41


List of Figure

List of Figures

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Thomas Jefferson University, Medical Devices Deals, 2012 to YTD 2018 10


List of Table

List of Tables

Thomas Jefferson University, Pharmaceuticals & Healthcare, Key Facts 2

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Thomas Jefferson University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Thomas Jefferson University, Deals By Therapy Area, 2012 to YTD 2018 9

Thomas Jefferson University, Medical Devices Deals, 2012 to YTD 2018 10

Thomas Jefferson University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Genisphere Enters into Research Agreement with Sidney Kimmel 12

Bio-Path Enters into Research Agreement with Thomas Jefferson University 13

Exosome Sciences Enters into Research Agreement with Thomas Jefferson 14

Imcare Biotech Enters into Development Partnership with Thomas Jefferson University 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Nanobiotix Enters Into Co-Development Agreement With Thomas Jefferson University For Nbtxr3 17

Abington Health Merges with Thomas Jefferson University 18

BioVaxys Enters into Licensing Agreement with Thomas Jefferson University 19

Junaxo Enters into Licensing Agreement with Thomas Jefferson University 20

Clementia Pharma Enters into Licensing Agreement with Thomas Jefferson University 21

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 23

Thomas Jefferson University, Key Competitors 24

Thomas Jefferson University, Key Employees 25

Thomas Jefferson University, Other Locations 26

Thomas Jefferson University, Subsidiaries 26

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022